Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 199 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2007Intracortical inhibition in the human trigeminal motor systemJaberzadeh, S.; Pearce, S.; Miles, T.; Turker, K.; Nordstrom, M.
2013HIV non-B subtype distribution: Emerging trends and risk factors for imported and local infections newly diagnosed in South AustraliaHawke, K.; Waddell, R.; Gordon, D.; Ratcliff, R.; Ward, P.; Kaldor, J.
2010MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinomaWijnhoven, B.; Hussey, D.; Watson, D.; Tsykin, A.; Smith, C.; Michael, M.
2008Cortisol inhibits neuroplasticity induction in human motor cortexSale, M.; Ridding, M.; Nordstrom, M.
2011For all my family's sake, I should go and find out: An Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancerWakefield, C.; Ratnayake, P.; Meiser, B.; Suthers, G.; Price, M.; Duffy, J.; Tucker, K.
2009Effect of experimental pain on EMG-activity in human jaw-closing muscles in different jaw positionsBaad-Hansen, L.; Hara, S.; Marumo, Y.; Miles, T.; Svensson, P.
2005Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentaeVanderlelie, J.; Venardos, K.; Clifton, V.; Gude, N.; Clarke, F.; Perkins, A.
2011MLVA and phage typing as complementary tools in the epidemiological investigation of Salmonella enterica serovar typhimurium clustersRoss, I.; Davos, D.; Mwanri, L.; Raupach, J.; Heuzenroeder, M.
2012Initial molecular response at 3 months may predict both response and event-free survival at 24 months in Imatinib-resistant or -intolerant patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with NilotinibBranford, S.; Kim, D.; Soverini, S.; Haque, A.; Shou, Y.; Woodman, R.; Kantarjian, H.; Martinelli, G.; Radich, J.; Saglio, G.; Hochhaus, A.; Hughes, T.; Muller, M.
2011Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high Vancomycin minimum inhibitory concentrationsHolmes, N.; Turnidge, J.; Munckhof, W.; Robinson, J.; Korman, T.; O'Sullivan, M.; Anderson, T.; Roberts, S.; Gao, W.; Christiansen, K.; Coombs, G.; Johnson, P.; Howden, B.